Cochlear suffers first 'strike'

30% of shareholders vote down remuneration report

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

More than 30% of shareholders voted against Cochlear Limited's (ASX: COH) remuneration report today, which included the grant of share options worth more than $1 million to CEO Chris Roberts.

That has handed the hearing implant maker its first strike under the government's controversial two-strike rule. If more than 25% of shareholders vote against its remuneration policy in two consecutive years, it triggers a so-called board spill, in which directors can be forced to stand for re-election.

The strike price for the options was set at $62.78, despite not vesting for three years and compared to the last closing price of $71.18. That means there's absolutely no incentive for the CEO to earn those options, as they are already profitable.  The award of the options was also despite the company reporting a 68% drop in net profits for the 2012 financial year, following a voluntary recall of its latest hearing implant, the Nucleus CI500. The company suffered large costs as it recalled the CI500 products and had to increase production of a replacement implant.

The Australian Shareholder Association (ASA) had raised concerns over the issue with Cochlear's chairman prior to the meeting, and announced that it had intended to vote against the resolution.

116 companies face a second strike this year, according to the Australian Financial Review, including News Corporation (ASX: NWS), Stockland (ASX: SGP) and CSL Limited (ASX: CSL).

Cochlear chairman, Rick Holliday-Smith has apologised to shareholders, suggesting that the company should have been engaging with shareholders much earlier. Despite the hiccup, Cochlear looks set to have a much better 2013 financial year. As the world's population ages, more and more people want to maintain their hearing. In developed markets, the over 65s age bracket is the company's fastest growing sector.

If you only invest in one company this year, make it our "Top Stock for 2012-13". Operating in two hot markets — one set to double by 2012, the other predicted to grow 5x over the next five years — this stock is a solid growth play that also boasts strong recurring revenue, zero debt, and lots of cash. Get its name and full research case in this brand-new FREE report.

More reading

Motley Fool writer/analyst Mike King owns shares in Cochlear and CSL. The Motley Fool's purpose is to help the world invest, better. Take Stock is The Motley Fool's free investing newsletter. Packed with stock ideas and investing advice, it is essential reading for anyone looking to build and grow their wealth in the years ahead. Click here now to request your free subscription, whilst it's still available. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »